Earnings History Data for Cognition Therapeutics, Inc. (CGTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Cognition Therapeutics, Inc.
Cognition Therapeutics Inc.is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Cognition Therapeutics Inc.is based in PURCHASE, N.Y.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-03-2024 | PM | CGTX | Cognition Therapeutics, Inc. | 57.49 | -0.27 | -0.38 | -0.20 | Cognition Therapeutics reports FY results [3/26/2024 11:30 AM] |
1.82 | 0.0 (0.00%) |
1.87 | 0.05 (2.75%) |
0.90 - 3.49 | 48,170 | 290,000 | 578 | ||
| 02-11-2023 | PM | CGTX | Cognition Therapeutics | 34.00 | -0.22 | -0.31 | 0.00 | Cognition Therapeutics GAAP EPS of $0.22 beats by $0.46 [11/2/2023 11:24 AM] |
1.05 | -0.04 (-3.79%) |
1.13 | 0.04 (3.67%) |
1.00 - 3.51 | 99,430 | 330,000 | 171 | ||
| 08-08-2023 | PM | CGTX | Cognition Therapeutics, Inc. | 51.82 | -0.16 | -0.25 | -0.25 | Cognition Therapeutics GAAP EPS of -$0.16 [8/8/2023 7:23 AM] |
1.71 | -0.03 (-1.44%) |
1.82 | 0.08 (4.90%) |
1.07 - 3.51 | 28,314 | 50,000 | 2,089 | ||
| 04-05-2023 | AH | After the close (May 4) |
CGTX | Cognition Therapeutics | 47.00 | -0.21 | -0.17 | 0.00 | Cognition Therapeutics GAAP EPS of -$0.21 misses by $0.03 [5/4/2023 6:13 PM] |
1.58 | -0.09 (-5.39%) |
0.0 | 0.0 (0.00%) |
1.07 - 6.27 | 43,913 | 20,000 | 0 | |
| 23-03-2023 | PM | 8:00 AM ET (Mar 23) |
CGTX | Cognition Therapeutics, Inc. | 50.44 | -0.20 | 0.00 | 0.00 | Cognition Therapeutics GAAP EPS of -$0.91 misses by $0.68 [3/23/2023 7:48 AM] |
1.83 | -0.03 (-1.61%) |
1.90 | 0.04 (2.15%) |
1.07 - 6.27 | 44,804 | 80,000 | 4,741 | |
| 14-11-2022 | PM | CGTX | Cognition Therapeutics | 27.00 | -0.29 | -0.55 | 0.00 | Cognition Therapeutics GAAP EPS of -$0.29 beats by $0.09 [11/14/2022 9:20 AM] |
1.24 | -0.08 (-6.06%) |
0.0 | 0.0 (0.00%) |
1.07 - 12.05 | 71,018 | 140,000 | 0 | ||
| 09-08-2022 | PM | 7:00 AM ET (Aug 9) |
CGTX | Cognition Therapeutics, Inc. | 47.91 | -0.25 | -0.31 | 0.00 | Cognition Therapeutics GAAP EPS of -$0.25 beats by $0.07 [8/9/2022 7:27 AM] |
2.64 | -0.13 (-4.69%) |
2.60 | -0.17 (-6.14%) |
1.50 - 13.80 | 432,293 | 2,860,000 | 7,100 | |
| 11-05-2022 | PM | 8:00 AM ET (May 11) |
CGTX | Cognition Therapeutics, Inc. | 62.37 | -0.17 | -0.27 | 0.00 | Cognition Therapeutics GAAP EPS of $0.17 beats by $0.46 [5/11/2022 7:23 AM] |
2.55 | -0.15 (-5.56%) |
0.0 | 0.0 (0.00%) |
2.31 - 13.80 | 52,129 | 50,000 | 0 | |
| 30-03-2022 | PM | 8:00 AM ET (Mar 30) |
CGTX | Cognition Therapeutics, Inc. | 66.99 | N/A | -0.19 | 0.00 | Cognition Therapeutics GAAP EPS of -$3.13 misses by $2.64 [3/30/2022 7:06 AM] |
2.72 | -0.25 (-8.58%) |
0.0 | 0.0 (0.00%) |
2.31 - 13.80 | 50,508 | 100,000 | 0 | |